Home > Insider Trading > Filing (0001779453-21-000004)

Filing Details

Accession Number:: 0001779453-21-000004
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-09 18:39:06
Reporting Period:: 2021-02-05

Accepted Time:: 2021-02-09 18:39:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1652724	Lucira Health Inc.	LHDX	In Vitro & In Vivo Diagnostic Substances (2835)	272491037

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1779451	Chad Boeding	One Lombard Street, Suite 200 San Francisco CA 94111	No	No	No	Yes
1779453	Epiq Capital Group, Llc	One Lombard Street, Suite 200 San Francisco CA 94111	No	No	Yes	No
1798799	Epq Llc, Lflu Ps	9650 Gateway Drive, Suite 200 Reno NV 89521	No	No	No	Yes
1818376	Epq Llc, Lcovd Ps	9650 Gateway Drive, Suite 200 Reno NV 89521	No	No	Yes	No
1833912	Epq Llc, Lcovd Safe Ps	9650 Gateway Drive, Suite 200 Reno NV 89521	No	No	No	Yes
1841495	Epq Llc, Ltest Ps	9650 Gateway Drive, Suite 200 Reno NV 89521	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-05	32,176	$0.00	32,176	No	4	C	Direct
Common Stock	Acquisiton	2021-02-05	3,754,084	$0.00	3,754,084	No	4	C	Direct
Common Stock	Acquisiton	2021-02-05	5,173,026	$0.00	5,173,026	No	4	C	Direct
Common Stock	Acquisiton	2021-02-05	735,475	$17.00	735,475	No	4	C	Direct
Common Stock	Acquisiton	2021-02-05	3,461,764	$17.00	3,461,764	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred	Disposition	2021-02-05	32,176	$0.00	32,176	$0.00
Common Stock	Series B Convertible Preferred	Disposition	2021-02-05	3,754,084	$0.00	3,754,084	$0.00
Common Stock	Series C Convertible Preferred	Disposition	2021-02-05	5,173,026	$0.00	5,173,026	$0.00
Common Stock	2020B Convertible Promissory Note	Disposition	2021-02-05	735,475	$17.00	735,475	$0.00

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Direct
	No	4	C	Direct
	No	4	C	Direct
2022-12-11	No	4	C	Direct

Footnotes

Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
The convertible promissory note automatically converted into shares of the Issuer's Common Stock upon the closing of the IPO.
Chad Boeding is the beneficial owner of these shares through a trust that he controls.
EPQ LLC, LFLU PS ("LFLU") is the direct beneficial owner of these shares.
EPQ LLC, LCOVD PS ("LCOVD") is the direct beneficial owner of these shares.
EPQ LLC, LCOVD SAFE PS ("SAFE") is the direct beneficial owner of this shares.
EPQ LLC, LTEST PS ("LTEST") is the direct beneficial owner of these shares.
EPIQ Capital Group, LLC ("EPIQ") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares).
The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.